Filters: Author is Ke, Chunlei [Clear All Filters]
Antineoplastic Agents, Immunological
Clinical Trials as Topic
Clinical Trials, Phase III as Topic
A counterfactual p-value approach for benefit-risk assessment in clinical trials." J Biopharm Stat 25, no. 3 (2015): 508-24."
Data Interpretation, Statistical
Decision Support Techniques
Head and Neck Neoplasms
Predictive Value of Tests
Randomized Controlled Trials as Topic
Squamous Cell Carcinoma of Head and Neck
Biomarker threshold adaptive designs for survival endpoints." J Biopharm Stat 28, no. 6 (2018): 1038-1054."